शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsHighNegative
Announced Fri, 16 May, 2025 · 18:05 IST

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby inform you that "KNAV Corporate Finance (A Division of Inde Global Consulting LLP)" has filed a petition against the Company under Section 9 of the Insolvency and Bankruptcy Code, 2016.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.7%Reaction day
₹137.94
prior close
₹139.80
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.2%-2.9% vs market

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.7
15m
-1.3
30m
-2.1
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-1.7+1.2-2.9
Next day
-2.1+0.1-2.2
2d
-0.7+0.9-1.6
3d
-2.2+0.8-3.0
4d
-2.5+1.4-3.9
5d
-1.5+2.0-3.5
1w
-6.1+2.3-8.4
15d
-5.6+5.2-10.8
1m
-7.0+1.6-8.5
2m
+15.2+7.7+7.6
3m
+10.9+4.0+6.9
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KNAV Corporate Finance (a division of Inde Global Consulting LLP) has filed an insolvency petition against Brooks Laboratories before the NCLT Chandigarh Bench under Section 9 of the Insolvency and Bankruptcy Code, 2016. The petition (CP (IB) No. 62/CHD/HP/2025) claims an alleged outstanding amount of approximately Rs. 1.12 crore. The company has stated that it strongly disputes the claim and believes the petition is not maintainable under the IBC. Brooks Labs will contest the matter on both procedural and substantive grounds, and the petition has not yet been admitted by the NCLT.

Likely market impact

Negative near-term sentiment is possible as insolvency petitions often weigh on stock price, though the contested amount is relatively small and the case is in early stages. Shareholders should monitor NCLT hearings and any admission order, as admission would trigger CIRP and potential management changes.